iRegained logo

About us

IRegained is a digital neurotherapeutics (DTx) company that has developed an FDA-registered, patented, smart, digital rehabilitation system that helps patients “rewire” their brain through the power of neuroplasticity, empowering people who have suffered a stroke, TBI or musculoskeletal injury, reclaim unassisted use of their hands. The MyHand® System has been clinically validated and is now available for commercial sale.

The System is a “smart”, cloud-connected, mechatronic device with clinically-effective, targeted finger and hand training protocols that enhance neuroplasticity and accelerate recovery of lost hand function.

Patients have demonstrated an improved ability to grasp and perform basic activities of daily living after only a few weeks of therapy. The System also incorporates a scientifically robust, engaging and gamified interface to promote neuroplasticity and encourage adherence to rehabilitation plans.

Program engagement

Leadership

Vineet Johnson

Founder & CEO

Samir Sahoo

COO & VP Business Development

Joel Liederman

Head, Strategic Partnerships

Status

Intellectual Property

Fundraising

In Market

Sector

Subsector

Synapse Life Science Pitch Competition applications open. Apply by November 10, 2024

Applications for the 2025 Synapse Competition are open!

The Synapse Life Science Competition combines the ideas and research of life science innovators with the intellect and strategy of students. Finalists receive training, mentorship, a $2,000 grant and a chance to pitch and compete for BIG cash prizes!

Applications close on November 10, 2024.